V-DOS-47

N/A

Report date: 2024/11/21 15:14:58

Base Information

Drug NameV-DOS-47
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Non-cleavable linker > Maleimide PEG linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)
Mechanisms of ActionAnti-Vascular endothelial growth factor receptor 2Urease stimulants
TargetsVascular endothelial growth factor receptor 2Urease
Therapy Area/IndicationsBreast NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHelix Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHelix BiopharmaNational Research Council CanadaHelix Immuno-Oncology SA
Active IndicationsN/A
Inactive IndicationsBreast NeoplasmsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A